Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

Clinical trial NCT00256750 · COMPLETED

Trial details

NCT number: NCT00256750
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplantation Chronic Kidney Failure

Start date: 2005-03-01
Primary completion: 2008-06-01
Enrollment: 738

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.